Free tool
Diagnostics stocks
We cover 7 companies grouped under the Diagnostics theme. The median market value in the group is $14.63B. Across the group, the median move over the past trading day is 0.00%. Price change over the past year runs from −21.9% to +27.4% across the middle 80 percent of the group, with a median of +11.0%.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
7 of 150 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| 0KSX.L | Quest Diagnostics Incorporated | $27.60B | Large cap | +36.94% |
| 0JSY.L | Labcorp Holdings Inc. | $27.37B | Large cap | +20.97% |
| ERF.PA | Eurofins Scientific SE | $14.91B | Large cap | +13.76% |
| ESF0.DE | Eurofins Scientific SE | $14.63B | Large cap | +11.02% |
| BIM.PA | bioMérieux S.A. | $10.40B | Large cap | −37.52% |
| QIA.DE | Qiagen N.V. | $8.85B | Mid cap | −11.42% |
| ALIF-B.ST | AddLife AB (publ) | $2.09B | Mid cap | −7.56% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.